Management of Resistant Hypertension-An Update

JAMA Intern Med. 2024 Apr 1;184(4):433-434. doi: 10.1001/jamainternmed.2023.8555.

Authors

John M Giacona^{1

2}, Weerapat Kositanurit^{1

3}, Wanpen Vongpatanasin¹

Affiliations

¹ Hypertension Section, Cardiology Division, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas.
² Department of Applied Clinical Research, School of Health Professions, University of Texas Southwestern Medical Center, Dallas.
³ Department of Physiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.

PMID: 38372970
DOI: 10.1001/jamainternmed.2023.8555

No abstract available

Plain language summary

This JAMA Internal Medicine Clinical Insights review provides an update on the current recommendations for resistant hypertension management.

MeSH terms

Antihypertensive Agents / therapeutic use
Evidence-Based Medicine
Humans
Hypertension* / drug therapy

Substances

Antihypertensive Agents